C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2011
12/15/2011	US20110306125 Protein Expression Methods
12/15/2011	US20110306106 High expression promoter and method for producing gene product using same
12/15/2011	US20110306099 Method of cloning dna
12/15/2011	US20110306098 Compositions and methods for use in isolation of nucleic acid molecules
12/15/2011	US20110306096 Biotinylation tag peptides
12/15/2011	US20110306092 Expression vector system comprising two selection markers
12/15/2011	US20110306091 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
12/15/2011	US20110306090 Mammalian Expression Vector
12/15/2011	US20110306074 Glycosyltransferase reversibility for sugar nucleotide synthesis
12/15/2011	US20110306062 Babesia microti genomic clones containing novel antigens useful in the diagnosis of babesios
12/15/2011	US20110306044 Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereof
12/15/2011	US20110306040 Cpg receptor (cpg-r) and methods relating thereto
12/15/2011	US20110305763 Lantibiotics and uses thereof
12/15/2011	US20110305725 Methods and compositions for immunizing pigs against porcine circovirus
12/15/2011	US20110305724 Immunotherapeutic, anti-tumorigenic compositions and methods of use thereof
12/15/2011	US20110305723 Molecular Antigen Array
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/15/2011	US20110305718 Recombinant Protein Body-Inducing Polypeptides
12/15/2011	US20110305714 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
12/15/2011	US20110305712 Ctla4 proteins and their uses
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305703 Isolated vegf-c and vegf-d peptides and uses thereof
12/15/2011	US20110305702 Epitopes
12/15/2011	US20110305701 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases
12/15/2011	US20110305697 Fc fusion proteins
12/15/2011	US20110305696 anti-serum albumin binding variants
12/15/2011	US20110305694 Multivalent and/or multispecific rankl-binding constructs
12/15/2011	US20110305693 Anitigen-binding constructs
12/15/2011	US20110305691 Modified polypeptides stabilized in a desired conformation and methods for producing same
12/15/2011	US20110305687 Anti-fgfr2 antibodies
12/15/2011	US20110305686 Therapies for chronic renal failure using one or more integrin antagonists
12/15/2011	US20110305685 Supramolecular approach for preparation of size controllable nanoparticles
12/15/2011	US20110305670 Nucleic acid encoding fusion polypeptides that prevent or inhibit hiv infection
12/15/2011	US20110305664 Novel vaccines against multiple subtypes of influenza virus
12/15/2011	US20110305663 Serum albumin binding molecules
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	DE102010056626A1 Bypassing end replication defect comprises replacing RNA primers by RNAse H from DNA strand during cell division, which activates new DNA strand e.g. by neurotransmitters, hence new cell division arises and chromosomes do not become shorter
12/15/2011	DE102010029973A1 Mikrobiologische Herstellung von C4-Körpern aus Saccharose und Kohlendioxid Microbiological production of C4 bodies of sucrose and carbon dioxide
12/15/2011	DE102010000168A9 Biokatalysator für die Hydroxylierung und /oder Epoxidierung Biocatalyst for hydroxylation and / or epoxidation
12/15/2011	DE102005011579B4 Affinitätsmarker zur Proteinreinigung, seine Herstellung und Verwendung sowie Verfahren zur Aufreinigung eines Proteins Affinity tag for protein purification, its preparation and use as well as methods for the purification of a protein
12/15/2011	CA2836977A1 Recombinant rna viruses and uses thereof
12/15/2011	CA2814155A1 Anti-tim-3 antibody
12/15/2011	CA2802186A1 Microorganism variants having hydrocarbon producing ability and method for producing hydrocarbon using the same
12/15/2011	CA2802167A1 Direct cloning
12/15/2011	CA2802089A1 Method for selective oligonucleotide modification
12/15/2011	CA2802059A1 Nucleic acid detection and quantification by post-hybridization labeling and universal encoding
12/15/2011	CA2802015A1 Cloning and expression of the genes encoding key clostridial catalyzing mechanisms for syngas to ethanol production and functional characterization thereof
12/15/2011	CA2801836A1 Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
12/15/2011	CA2801834A1 Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
12/15/2011	CA2801671A1 Optical transfection
12/15/2011	CA2801639A1 Vectors and sequences for the treatment of diseases
12/15/2011	CA2801634A1 Method for down-regulating gene expression in fungi
12/15/2011	CA2801608A1 Fusion proteins comprising a dna-binding domain of a tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use
12/15/2011	CA2801564A1 Compositions and methods for protein production
12/15/2011	CA2801501A1 Pathways characterization of cells
12/15/2011	CA2801293A1 Geminivirus replication inhibitor
12/15/2011	CA2800830A1 Vaccine and methods to reduce campylobacter infection
12/15/2011	CA2800534A1 Production of fertile xy female animals from xy es cells
12/15/2011	CA2798941A1 Regulatory sequences for modulating transgene expression in plants
12/15/2011	CA2795033A1 Rehydratable food
12/14/2011	EP2395112A1 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence
12/14/2011	EP2395095A1 In vivo screening models for treatment of Alzheimer's disease and other QPCT-related disorders
12/14/2011	EP2395094A2 Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans
12/14/2011	EP2395093A2 Plants having enhanced yield-related traits and a method for making the same
12/14/2011	EP2395092A2 Plants having enhanced yield-related traits and a method for making the same
12/14/2011	EP2395091A2 Plants having enhanced yield-related traits and a method for making the same
12/14/2011	EP2395090A1 Herbicide-resistant Brassica plants and methods of use
12/14/2011	EP2395089A1 Polynucleotide comprising sequences of wheat gliadins and use thereof for silencing by rnai
12/14/2011	EP2395088A1 A recombinant DNA molecule, vector, plant cell and plant expression cassette producing large amounts of functionally active cysteine synthase and use thereof
12/14/2011	EP2395087A1 System and method of modular cloning
12/14/2011	EP2395086A1 Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
12/14/2011	EP2395085A2 Small interference rna complex with increased intracellular transmission capacity
12/14/2011	EP2395084A1 Transgenic plants expressing CIVPS or intein modified proteins and related method
12/14/2011	EP2395083A1 Transgenic plants expressing CIVPS or intein modified proteins and related method
12/14/2011	EP2395082A1 Extraction of nucleic acids from wax-embedded samples
12/14/2011	EP2395081A1 Zinc finger nuclease-mediated homologous recombination
12/14/2011	EP2395080A1 Cellobiose 2-epimerase, process for producing same, and use of same
12/14/2011	EP2395079A1 Screening method
12/14/2011	EP2395076A1 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
12/14/2011	EP2395075A2 Recombinant ralstonia eutropha capable of producing polylactic acid or polylatic acid copolymer, and method for producing polylactic acid or polylatic acid copolymer using same
12/14/2011	EP2395041A1 Polymers for delivery of nucleic acids
12/14/2011	EP2395024A2 Modified antigen binding molecules with altered cell signaling activity
12/14/2011	EP2395023A2 Modified antigen binding molecules with altered cell signaling activity
12/14/2011	EP2395018A1 Human binding molecules having killing activity against staphylococci and uses thereof
12/14/2011	EP2395014A2 Silk proteins
12/14/2011	EP2395013A2 Proteins comprising conserved regions of Neisseria meningitidis surface antigen NhhA
12/14/2011	EP2395012A2 Modified siRNA molecules and uses thereof
12/14/2011	EP2394667A1 Vectors and sequences for the treatment of diseases
12/14/2011	EP2394661A1 Sp35 antibodies and uses thereof
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2394152A2 Nucleic acid purification
12/14/2011	EP2393945A1 Dual targeting of mir-208 and mir-499 in the treatment of cardiac disorders
12/14/2011	EP2393933A2 Rna-and dna-copying enzymes
12/14/2011	EP2393929A1 Variant axmi-r1 delta-endotoxin genes and methods for their use
12/14/2011	EP2393928A1 Use of trehalase to obtain drought resistance in plants
12/14/2011	EP2393927A1 Production of oligoclonal mixtures of immunoglobulins in single cells
12/14/2011	EP2393926A1 Compositions and methods for inhibiting expression of ptp1b genes
12/14/2011	EP2393925A1 Protein and dna sequence encoding a cold adapted xylanase
12/14/2011	EP2393924A1 Modification of multidomain enzyme for expression in plants
12/14/2011	EP2393828A1 Extended recombinant polypeptides and compositions comprising same

1 ... 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 ... 4023